{
  "resourceType": "Bundle",
  "id": "HighRiskReferral_JosephineGreene-past-breast-pain-adh-biopsy",
  "type": "collection",
  "entry": [
    {
      "fullUrl": "http://cancerscreeningcds.github.io/bcsm-cds/CarePlan/409",
      "resource": {
        "resourceType": "CarePlan",
        "id": "409",
        "subject": {
          "reference": "Patient/JosephineGreene",
          "display": "Josephine Greene"
        },
        "instantiatesCanonical": [
          "http://cancerscreeningcds.github.io/bcsm-cds/PlanDefinition/flow-HighRiskReferral"
        ],
        "intent": "proposal",
        "status": "draft",
        "created": "2024-12-10T00:00:00.0Z",
        "activity": [
          {
            "reference": {
              "reference": "RequestGroup/410"
            }
          }
        ]
      }
    },
    {
      "fullUrl": "http://cancerscreeningcds.github.io/bcsm-cds/RequestGroup/410",
      "resource": {
        "resourceType": "RequestGroup",
        "id": "410",
        "subject": {
          "reference": "Patient/JosephineGreene",
          "display": "Josephine Greene"
        },
        "instantiatesCanonical": [
          "http://cancerscreeningcds.github.io/bcsm-cds/PlanDefinition/flow-HighRiskReferral"
        ],
        "intent": "proposal",
        "status": "draft",
        "action": [
          {
            "id": "HighRiskReferralAtypicalBiopsy",
            "title": "Referral for high risk breast specialty evaluation",
            "description": "Consider referral to breast specialist to discuss primary risk reduction interventions such as chemoprevention.\n\nWomen at greater risk, such as those with a history of past atypical biopsy results, may derive more benefit than harm from risk-reducing medications.",
            "documentation": [
              {
                "type": "citation",
                "label": "USPSTF",
                "display": "Breast Cancer: Medication Use to Reduce Risk",
                "citation": "US Preventive Services Task Force. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(9):857â€“867.",
                "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction"
              }
            ],
            "resource": {
              "reference": "ServiceRequest/411"
            }
          }
        ]
      }
    },
    {
      "fullUrl": "http://cancerscreeningcds.github.io/bcsm-cds/ServiceRequest/411",
      "resource": {
        "id": "411",
        "resourceType": "ServiceRequest",
        "status": "option",
        "basedOn": [
          {
            "reference": "http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/HighRiskSpecialtyReferralRequest"
          }
        ],
        "subject": {
          "reference": "Patient/JosephineGreene",
          "display": "Josephine Greene"
        },
        "intent": "proposal",
        "code": {
          "coding": [
            {
              "code": "highriskreferral",
              "system": "http://cancerscreeningcds.github.io/bcsm-cds/CodeSystem/plan-definition-action-code-system",
              "display": "High risk referral"
            }
          ]
        },
        "reasonCode": [
          {
            "coding": [
              {
                "code": "Atypical",
                "system": "http://cancerscreeningcds.github.io/bcsm-cds/CodeSystem/biopsy-result-observation-code-system",
                "display": "Atypical breast finding"
              }
            ]
          }
        ]
      }
    }
  ]
}